Is Receptor-Interacting Protein Kinase 3 a Viable Therapeutic Target for Mycobacterium tuberculosis Infection?
Michael D. Stutz(Walter and Eliza Hall Institute of Medical Research), Marc Pellegrini(The University of Melbourne)
Cited by 15
Related Papers
IL-7 Engages Multiple Mechanisms to Overcome Chronic Viral Infection and Limit Organ Pathology
|Cell|2011|304
Adjuvant IL-7 antagonizes multiple cellular and molecular inhibitory networks to enhance immunotherapies
|Nature Medicine|2009|226
Necroptotic signaling is primed in Mycobacterium tuberculosis-infected macrophages, but its pathophysiological consequence in disease is restricted
|Cell Death and Differentiation|2017|84